Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Completed 5

Sponsor Class

OTHER 13INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 5

Conditions

Keratosis, Actinic 4Carcinoma, Basal Cell 2Warts 1Carcinoma, Squamous Cell 1Bowen's Disease 1

Interventions

Paclitaxel 337pembrolizumab 332Carboplatin 330Cisplatin 277Gemcitabine 264Docetaxel 251Bevacizumab 239Nivolumab 230Pemetrexed 211Rituximab 183Dexamethasone 183Cyclophosphamide 169Capecitabine 169Trastuzumab 149Fluorouracil 147Ipilimumab 121atezolizumab 118Prednisone 117Erlotinib Hydrochloride 116Oxaliplatin 109Cetuximab 104Sunitinib 101Leucovorin 97Doxorubicin 97Lenalidomide 93Irinotecan 89130-nm albumin-bound paclitaxel 84durvalumab 77Bortezomib 77Azacitidine 73

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Has results × Photochemotherapy × Clear all
NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Galderma R&D

Phase 3 Completed
82 enrolled 20 charts
Dermatologic

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

NCT00472108 2024-08-05

Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma

Galderma R&D

Phase 3 Completed
65 enrolled 15 charts
Dermatologic

Carcinoma, Basal Cell

NCT01966120 2023-07-28

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Biofrontera Bioscience GmbH

Phase 3 Completed
87 enrolled 21 charts
Dermatologic

Keratosis, Actinic

NCT02628236 2017-09-18

Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

DUSA Pharmaceuticals, Inc.

Phase 2 Completed
14 enrolled 39 charts
Dermatologic

Keratosis, Actinic

NCT02281136 2017-01-13

Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

DUSA Pharmaceuticals, Inc.

Phase 2 Completed
29 enrolled 34 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡